These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 9158256)
21. Selecting therapy for maintaining sexual function in patients with benign prostatic hyperplasia. Nehra A BJU Int; 2005 Aug; 96(3):237-43. PubMed ID: 16042709 [TBL] [Abstract][Full Text] [Related]
22. Medical treatment as an alternative to surgery in the management of benign prostatic hypertrophy. Bredin HC Ir Med J; 1996; 89(3):86, 88. PubMed ID: 8707527 [No Abstract] [Full Text] [Related]
23. [Uroselectivity of alpha-1 antagonism in the treatment of benign prostatic hypertrophy: on the pharmacologic concept of the clinical approach]. Jolliet P; Bourin M Therapie; 1998; 53(1):61-6. PubMed ID: 9773101 [TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of alpha-blocker utilization in combination with 5-alpha reductase inhibitors for enlarged prostate in a managed care setting among Medicare-aged men. Issa MM; Lin PJ; Eaddy MT; Shah MB; Davis EA Am J Manag Care; 2008 May; 14(5 Suppl 2):S160-6. PubMed ID: 18611090 [TBL] [Abstract][Full Text] [Related]
27. [Pharmacotherapy in benign prostatic hyperplasia]. Hauri D Ther Umsch; 1995 Jun; 52(6):378-82. PubMed ID: 7541566 [TBL] [Abstract][Full Text] [Related]
28. Treatment options in benign prostatic hypertrophy. Stone NN Hosp Pract (Off Ed); 1992 Oct; 27(10A):85-8, 91-2. PubMed ID: 1383248 [TBL] [Abstract][Full Text] [Related]
29. [Established and upcoming new options in medical therapy for benign prostatic hyperplasia]. Schlenker B; Beer AM; Gratzke C; Tilki D; Seitz M; Stief CG; Reich O MMW Fortschr Med; 2009 Oct; 151(41):33-6. PubMed ID: 19891182 [No Abstract] [Full Text] [Related]
30. The impact of medical therapy on surgery for benign prostatic hyperplasia: a study comparing changes in a decade (1992-2002). Vela-Navarrete R; Gonzalez-Enguita C; Garcia-Cardoso JV; Manzarbeitia F; Sarasa-Corral JL; Granizo JJ BJU Int; 2005 Nov; 96(7):1045-8. PubMed ID: 16225526 [TBL] [Abstract][Full Text] [Related]
31. Benign prostatic hyperplasia: from A - Z. Elhilali MM; Nickel JC Can J Urol; 2003 Apr; 10(2):1799-802. PubMed ID: 12773230 [TBL] [Abstract][Full Text] [Related]
32. BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE. Roehrborn CG BJU Int; 2008 Mar; 101 Suppl 3():17-21. PubMed ID: 18307681 [TBL] [Abstract][Full Text] [Related]
38. Medical management of prostatic diseases. Schlegel PN Adv Intern Med; 1994; 39():569-601. PubMed ID: 7511322 [TBL] [Abstract][Full Text] [Related]
39. [Prostatic adenoma: new drugs, new surgical techniques]. Heinzl S Med Monatsschr Pharm; 1992 Dec; 15(12):362-4. PubMed ID: 1282201 [No Abstract] [Full Text] [Related]
40. Is transurethral microwave thermotherapy an alternative to medical therapy for patients with benign prostatic hyperplasia? Djavan B Tech Urol; 2000 Dec; 6(4):300-6. PubMed ID: 11108570 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]